Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    19052126 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown 
Has Results
A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate;   Drug: adefovir dipivoxil
2 Unknown 
Has Results
A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of HBeAg Negative Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Tenofovir DF (TDF) 300 mg;   Drug: Double-blind adefovir dipivoxil (ADV) 10 mg (switch to open-label TDF 300 mg post Week 48)
3 Recruiting Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
Conditions: Hepatitis B Virus;   HIV;   Antiretroviral Therapy;   Africa;   Liver Fibrosis
Intervention: Other: Standard of care
4 Completed
Has Results
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir DF;   Drug: emtricitabine /tenofovir DF

Indicates status has not been verified in more than two years